Harvard Bioscience
HBIO
HBIO
87 hedge funds and large institutions have $121M invested in Harvard Bioscience in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 38 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
42% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 38
Holders
87
Holding in Top 10
1
Calls
$2K
Puts
–
Top Buyers
| 1 | +$1.76M | |
| 2 | +$1.46M | |
| 3 | +$789K | |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$647K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$539K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$508K | |
| 3 | -$487K | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$465K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$453K |